In a double-blind crossover design we compared dihydroxydibutylether (DHBE) with placebo in ten patients with cholesterol gallstones. The results showed that DHBE reduced (p less than 0.01) the bile saturation index (SI). The bile lipid composition demonstrated that the reduced SI was due to a decrease (p less than 0.01) in the molar percentage of cholesterol. There was no significant modification in biliary acid and phospholipid molar percentage.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patients cholesterol
8
cholesterol gallstones
8
molar percentage
8
double-blind comparative
4
comparative trial
4
trial dihydroxydibutylether
4
dihydroxydibutylether patients
4
gallstones double-blind
4
double-blind crossover
4
crossover design
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!